Answers are grounded in this paper and cite their sources.
The impact of MYC locus aberrations on the outcome of multiple myeloma (MM) patients is still a matter of debate. The aim of this study was to further investigate their influence on the survival of MM patients treated with high-dose chemotherapy. Our data suggest that the favorable prognosis factor
No takes yet. Share an insight, caveat, or question.
Weinhold et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: